Doctors’ Attitudes Towards E-Cigarettes: A Study in the US

Apr.16.2022
Electronic cigarettes may help smokers quit, but only 22% of US doctors recommend them, according to a study.

In the United States, approximately 480,000 people die from smoking each year. Despite the fact that the US Food and Drug Administration (FDA) has not yet approved electronic cigarettes as a smoking cessation device, many people ask their doctors whether using e-cigarettes can be a substitute for tobacco cigarettes or a way to help them quit smoking. E-cigarettes work by heating a liquid that contains nicotine.

 

According to Michael Steinberg, the Director of the Tobacco Dependence Program at Rutgers University's Tobacco Research Center and Chairman of the Department of Medicine at Rutgers Robert Wood Johnson Medical School, who is also the author of a research report, "As more and more evidence shows that electronic cigarettes may be effective for smoking cessation, they may play a key role in reducing cigarette usage and subsequent tobacco-related diseases. Understanding doctors' views on e-cigarettes as a harm-reduction tool is important.

 

This study, published in the online version of the Journal of the American Medical Association, surveyed 2,058 American doctors in 2018 and again in 2019 on their communication with patients about electronic cigarettes. Researchers asked how they would advise two different patients who want to quit smoking: a young woman with a mild addiction who has not yet attempted to quit, and an older man with a severe addiction who has tried multiple methods to quit in the past.

 

Only 22% of the surveyed doctors reported recommending e-cigarettes to their patients, with 10% stating they had done so within the 30 days prior to completing the questionnaire.

 

A recent study has found that doctors are three times more likely to recommend e-cigarettes to heavy smokers who have previously failed to quit smoking. Typically, doctors recommend FDA-approved medication such as nicotine gum or lozenges for mild smokers. Nearly 70% of doctors reported that their patients have asked them questions about e-cigarettes, with one-third saying they were asked within the past 30 days. More than 60% of doctors mistakenly believe that all tobacco products are equally harmful.

 

Cristine Delnevo, director of the Tobacco Research Center at Rutgers University and a professor of Health Behavior, Society and Policy at Rutgers School of Public Health, said, "These findings suggest that it is crucial to address doctors' misconceptions and educate them on the effectiveness of e-cigarettes, particularly in correcting the erroneous belief that all tobacco products are equally harmful, when in fact, combusted tobacco is by far the most dangerous.

 

The study also found that pulmonologists, cardiologists, and physicians who follow the clinical practice guidelines of the US Public Health Service for treating tobacco use and addiction are more likely to recommend e-cigarettes to patients, as well as those who hold harm reduction views and have a history of smoking themselves. However, if patients inquire about e-cigarettes first, physicians are also more likely to recommend them.

 

Source: Cnbeta

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Six Years of Data Show FDA Clearing PMTA Backlog
Six Years of Data Show FDA Clearing PMTA Backlog
FDA data from FY2020 to FY2025 show how the PMTA system for e-cigarette products evolved after an early surge of submissions created prolonged front-end delays. Millions of applications accumulated at the Acceptance stage before entering substantive review. Since 2023, the number of applications pending acceptance has declined sharply, and industry participants report shorter initial decision timelines in late 2025.
Feb.06
SICPA Secures Five-Year UK Vape Tax Stamp Contract
SICPA Secures Five-Year UK Vape Tax Stamp Contract
HM Revenue and Customs (HMRC) has awarded a five-year contract to Swiss technology company SICPA and Cartor Security Printers to implement the United Kingdom’s new vaping duty stamp and track-and-trace system, beginning in April 2026.
Market
Feb.24
China’s Tobacco Regulator Moves to Introduce Credit Management Framework for E-Cigarette Manufacturers, Greater Transparency May Improve International Assessability of China’s Supply Chain
China’s Tobacco Regulator Moves to Introduce Credit Management Framework for E-Cigarette Manufacturers, Greater Transparency May Improve International Assessability of China’s Supply Chain
China’s tobacco regulator has moved to introduce a credit management framework for e-cigarette manufacturers, outlining a system that links compliance records to regulatory oversight. The proposal forms part of a broader push to institutionalize supervision and improve transparency across China’s e-cigarette supply chain.
Jan.05
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI said on its latest earnings call that Japan’s tax cycle will weigh on 2026 performance, while smoke-free growth is expected to re-accelerate thereafter. The discussion also covered U.S. regulation, ZYN strategy and AI-driven efficiency.
Feb.07
China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China’s top tobacco regulator has issued a directive aimed at preventing excess capacity and curbing “involution-style” competition in the e-cigarette sector. The notice tightens investment controls, formalizes verified capacity management and requires exporters to submit compliance proof for destination markets, signaling a push toward higher industry concentration and stricter cross-border oversight.
Special Report
Feb.13
BAT FY2025 Results Review Series by 2Firsts
BAT FY2025 Results Review Series by 2Firsts
Feb.12